Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics,
pharmacodynamics and efficacy of 12 weeks of treatment with Apo805K1 in subjects with
moderate to severe chronic plaque psoriasis.